Stromal IL6 signaling has been shown to alter hormone metabolism in ER-negative breast cancers [11] and crosstalk between estrogen and IL6 signaling in the tumor microenvironment has been reported in prostate cancer cell lines [12]. This evidence concerns the gene IL6 and neoplasm.